​

Iovance Biotherapeutics (IOVA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Iovance Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$263.50M

Latest Revenue (Q)

$71.43M

Main Geography (Y)

UNITED STATES

Iovance Biotherapeutics Revenue by Period

Iovance Biotherapeutics Revenue by Year

DateRevenueChange
2025-12-31$263.50M60.60%
2024-12-31$164.07M13698.99%
2023-12-31$1.19M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Iovance Biotherapeutics generated $263.50M in revenue during NA 2025, up 60.60% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Iovance Biotherapeutics Revenue by Quarter

DateRevenueChange
2026-03-31$71.43M-17.68%
2025-12-31$86.77M28.64%
2025-09-30$67.45M12.52%
2025-06-30$59.95M21.55%
2025-03-31$49.32M-33.07%
2024-12-31$73.69M25.86%
2024-09-30$58.55M88.24%
2024-06-30$31.11M4250.49%
2024-03-31$715.00K48.34%
2023-12-31$482.00K2.77%
2023-09-30$469.00K97.06%
2023-06-30$238.00K100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31--

Iovance Biotherapeutics generated $71.43M in revenue during Q1 2026, up -17.68% compared to the previous quarter, and up 96.93% compared to the same period a year ago.

Iovance Biotherapeutics Revenue Breakdown

Iovance Biotherapeutics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 23Jun 23
Product$500.00K$200.00K

Iovance Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Product (100.00%).

Iovance Biotherapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 25Dec 24Dec 23
UNITED STATES$259.01M$161.04M-
Non-US$4.49M$3.03M$1.20M

Iovance Biotherapeutics's latest annual revenue breakdown by geography, as of Dec 25: UNITED STATES (98.30%), and Non-US (1.70%).

Quarterly Revenue by Country

CountryMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23
Non-US$958.00K$1.28M$1.05M$1.35M$804.00K$1.59M$740.00K$700.00K$500.00K$500.00K$200.00K
UNITED STATES$70.47M$85.49M$66.40M$58.60M$48.52M$103.23M$57.81M----

Iovance Biotherapeutics's latest quarterly revenue breakdown by geography, as of Mar 26: UNITED STATES (98.66%), and Non-US (1.34%).

Iovance Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IOVAIovance Biotherapeutics$263.50M$71.43M
DNAGinkgo Bioworks$170.16M-
CTMXCytomX Therapeutics$76.20M$10.26M
VIRVir Bio$68.56M$-29.00K
MGTXMeiraGTx$33.28M$293.00K
MLTXMoonLake Immunotherapeutics--
REPLReplimune Group--
MBXMBX Biosciences--
ERASErasca--
AVBPArriVent BioPharma--

IOVA Revenue FAQ

What is Iovance Biotherapeutics’s yearly revenue?

Iovance Biotherapeutics's yearly revenue for 2025 was $263.5M, representing an increase of 60.60% compared to 2024. The company's yearly revenue for 2024 was $164.07M, representing an increase of 13698.99% compared to 2023. IOVA's yearly revenue for 2023 was $1.19M, representing an increase of 100.00% compared to 2022.

What is Iovance Biotherapeutics’s quarterly revenue?

Iovance Biotherapeutics's quarterly revenue for Q1 2026 was $71.43M, a -17.68% decrease from the previous quarter (Q4 2025), and a 44.82% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $86.77M, a 28.64% increase from the previous quarter (Q3 2025), and a 17.74% increase year-over-year (Q4 2024). IOVA's quarterly revenue for Q3 2025 was $67.46M, a 12.52% increase from the previous quarter (Q2 2025), and a 15.20% increase year-over-year (Q3 2024).

What is Iovance Biotherapeutics’s revenue growth rate?

Iovance Biotherapeutics's revenue growth rate for the last 3 years (2023-2025) was 22061.65%, and for the last 5 years (2021-2025) was 0%.